Real Time PCR Machines

Real Time PCR Machines Market Outlook

The global Real Time PCR (Polymerase Chain Reaction) machines market is projected to reach approximately USD 5.2 billion by 2035, with a compound annual growth rate (CAGR) of around 8.4% during the forecast period from 2025 to 2035. This robust growth is primarily driven by the increasing prevalence of infectious diseases, advancements in molecular diagnostics, and the rising demand for personalized medicine. Furthermore, the surge in research and development activities, particularly in genomics and proteomics, is fueling the adoption of real-time PCR technologies across various sectors, including healthcare, pharmaceuticals, and biotechnology. Additionally, the ongoing innovations in PCR technology, such as the development of portable and high-throughput machines, are expected to enhance the market's growth potential.

Growth Factor of the Market

The growth of the Real Time PCR machines market can be attributed to several key factors. Firstly, the global increase in the incidence of infectious diseases, especially in light of the COVID-19 pandemic, has necessitated the need for rapid and accurate diagnostic tools, with real-time PCR emerging as a preferred choice due to its sensitivity and specificity. Secondly, the escalating investment in healthcare infrastructure, particularly in developing regions, is anticipated to drive demand for advanced diagnostic equipment. Moreover, the technological advancements in PCR machines, such as enhanced automation and integration capabilities, are making these devices more user-friendly and efficient, thus attracting a broader customer base. Additionally, the growing focus on personalized medicine and targeted therapies in oncology and other therapeutic areas has further propelled the demand for real-time PCR applications in clinical diagnostics. Finally, the increasing adoption of molecular biology techniques in academic and research institutions is contributing to the market's upward trajectory.

Key Highlights of the Market

• The global Real Time PCR machines market is expected to reach USD 5.2 billion by 2035.
• The market is projected to grow at a CAGR of 8.4% between 2025 and 2035.
• Rising prevalence of infectious diseases driving demand for rapid diagnostics.
• Technological advancements enhancing the capabilities and efficiency of PCR machines.
• Increasing focus on personalized medicine and targeted therapies in healthcare.

By Product Type

Standard Real Time PCR Machines:

Standard Real Time PCR machines are widely utilized in laboratories for quantitative analysis of nucleic acids. These machines are characterized by their ability to perform real-time monitoring of PCR amplification processes, providing results with high accuracy and speed. The growing demand for precise and timely diagnostics in clinical settings, as well as in research laboratories, is a significant factor contributing to the expansion of this product segment. Additionally, advancements in technology, such as improved optics and data analysis software, are enhancing the performance and reliability of standard real-time PCR machines. As a result, this segment is expected to hold a considerable share of the market throughout the forecast period.

Digital Real Time PCR Machines:

Digital Real Time PCR machines offer a transformative approach to nucleic acid quantification. Unlike traditional quantitative PCR, digital PCR enables absolute quantification by partitioning the sample into numerous reactions, thus enhancing sensitivity and precision. This innovation is particularly beneficial for applications requiring low detection limits, such as rare mutation analysis and copy number variation. The increasing need for high-throughput screening in research and clinical diagnostics is propelling the adoption of digital real-time PCR machines, making them a prominent segment in the market. Furthermore, the ability of these machines to provide robust data in challenging scenarios is driving their popularity among researchers and clinicians alike.

Portable Real Time PCR Machines:

Portable Real Time PCR machines are gaining traction due to their ease of use and ability to deliver accurate results in remote or point-of-care settings. These compact devices facilitate on-site testing, which is crucial in areas with limited access to laboratory facilities. The rising demand for rapid diagnostics, particularly in emergency situations and outbreak responses, is significantly boosting the market for portable PCR machines. Furthermore, advancements in battery life and connectivity options have made these devices more user-friendly and efficient, thereby expanding their applications in various fields, including environmental monitoring and veterinary diagnostics. This segment is expected to witness substantial growth as healthcare professionals increasingly rely on portable solutions for timely decision-making.

High-throughput Real Time PCR Machines:

High-throughput Real Time PCR machines are designed to accommodate a large number of samples simultaneously, making them ideal for large-scale genomic studies and population-based research. With the increasing focus on genomics and personalized medicine, the demand for high-throughput solutions is surging. These machines enable researchers to conduct extensive screening and analysis efficiently, thus significantly reducing the time and labor associated with traditional methods. The ability to multiplex assays further enhances their appeal, allowing for the simultaneous detection of multiple targets in a single reaction. As such, the high-throughput PCR segment is anticipated to experience robust growth, driven by the need for efficiency and scalability in molecular diagnostics.

Low-throughput Real Time PCR Machines:

Low-throughput Real Time PCR machines serve as essential tools in clinical and research laboratories where the volume of samples is manageable. These machines are often favored for their cost-effectiveness and simplicity, making them an accessible option for small laboratories and research settings. The increasing emphasis on genetic research and diagnostics in various biomedical fields is fostering the growth of the low-throughput segment. Moreover, the ease of use and minimal operational costs associated with these machines make them attractive to laboratories focused on routine applications. As such, this segment is poised to maintain a steady growth rate, supported by ongoing advancements in PCR technology and methodologies.

By Application

Clinical Diagnostics:

The application of Real Time PCR machines in clinical diagnostics is one of the most significant drivers of market growth. These machines provide rapid and reliable results for a variety of infectious diseases, genetic disorders, and cancers, paving the way for timely interventions and treatment plans. The urgency for accurate diagnostics, especially evident in the wake of recent global health crises, has underscored the importance of real-time PCR in clinical settings. Furthermore, the growing trend towards personalized medicine is increasing the demand for precise molecular diagnostics, further boosting the adoption of Real Time PCR machines in laboratories. With advancements in assay development and automation, the clinical diagnostics segment is expected to remain a dominant force in the market.

Research:

Real Time PCR machines play a crucial role in research laboratories, facilitating a wide range of applications, from gene expression analysis to genomic mapping. Researchers rely on these machines for their efficiency, accuracy, and ability to handle complex assays. The expansion of genomic research, fueled by the increasing number of research initiatives and funding in the life sciences, is significantly driving the demand for Real Time PCR technologies. Additionally, the versatility of real-time PCR techniques allows for their application in various fields, including environmental biology, agriculture, and veterinary sciences. As research continues to advance, the market for Real Time PCR machines is expected to expand further, driven by new discoveries and innovations across diverse scientific disciplines.

Forensics:

The application of Real Time PCR in forensic science has become increasingly indispensable, particularly in the areas of DNA analysis and criminal investigations. The ability of PCR to amplify minute quantities of DNA makes it a powerful tool for forensic analysts striving to obtain accurate results from degraded or compromised samples. The ongoing developments in forensic technologies and methodologies are propelling the use of Real Time PCR machines in forensic laboratories. Moreover, the increasing emphasis on swift and reliable forensic analysis in legal settings is further enhancing the market potential for real-time PCR technologies. As forensic science evolves, the demand for these machines is expected to grow significantly, highlighting their critical role in law enforcement and legal proceedings.

Others:

Other applications of Real Time PCR machines include their use in veterinary diagnostics, food safety testing, and agricultural research. In veterinary medicine, PCR technologies are employed for the detection of pathogens in animals, ensuring food safety and public health. In the field of agriculture, Real Time PCR is utilized for the genetic analysis of plants to improve crop yield and resistance. These varied applications demonstrate the versatility of Real Time PCR technology beyond traditional clinical and research settings. As awareness of the importance of molecular diagnostics in various sectors increases, this segment is anticipated to contribute positively to the overall market growth.

By Distribution Channel

Online Stores:

Online stores have become a significant distribution channel for Real Time PCR machines, offering convenience and accessibility to customers worldwide. The rise of e-commerce platforms has enabled laboratories and research institutions to explore a wider range of products beyond their local suppliers. Customers benefit from competitive pricing, detailed product information, and user reviews when purchasing PCR machines online. Additionally, the COVID-19 pandemic has accelerated the trend of online shopping, leading to an increase in online sales of laboratory equipment, including Real Time PCR machines. As more organizations favor online procurement due to its efficiency, this distribution channel is expected to dominate the market.

Specialty Stores:

Specialty stores that focus on laboratory equipment and supplies represent another crucial distribution channel for Real Time PCR machines. These stores often provide expert advice and a curated selection of high-quality products, catering to the specific needs of laboratories and researchers. The personalized service and direct interaction with knowledgeable staff enhance the purchasing experience, allowing customers to make informed decisions. Additionally, specialty stores may offer unique product lines or brands that are not available through broader retail outlets. As research institutions and laboratories continue to seek specialized equipment, specialty stores are likely to maintain a strong position in the market.

Direct Sales:

Direct sales from manufacturers to end-users represent a significant channel for distributing Real Time PCR machines. This approach allows manufacturers to forge strong relationships with customers by providing tailored solutions and technical support. Direct sales can also streamline the purchasing process, reducing lead times and ensuring that customers receive equipment that meets their specific operational needs. Additionally, manufacturers often conduct training and demonstrations as part of the direct sales process, enhancing customer satisfaction and product understanding. As manufacturers seek to improve customer engagement and service quality, direct sales are expected to remain a vital distribution channel in the Real Time PCR machines market.

Others:

Other distribution channels for Real Time PCR machines may include wholesalers, value-added resellers, and government procurement programs. Wholesalers play a crucial role in the supply chain by connecting manufacturers with a broader range of customers, while value-added resellers provide additional services, such as installation and maintenance, alongside equipment sales. Government procurement programs, particularly in healthcare settings, can also influence the distribution of PCR machines, as public institutions often require compliance with specific regulations and standards. As the market evolves, these varied distribution channels will continue to contribute to the accessibility and availability of Real Time PCR technologies.

By Technology Type

SYBR Green PCR:

SYBR Green PCR technology is a widely adopted method in real-time PCR applications due to its simplicity and cost-effectiveness. This method relies on a dye that binds to double-stranded DNA, allowing for the detection of PCR products as they accumulate during the amplification process. The ease of use and minimal setup requirements make SYBR Green PCR a popular choice for many laboratories, particularly in research applications. However, the potential for non-specific amplification can be a limitation, driving researchers to explore alternative methods. Despite this, the segment remains strong, particularly in settings where budget constraints are a primary consideration, and the need for efficient quantification is paramount.

TaqMan PCR:

TaqMan PCR technology utilizes a dual-labeled probe system, offering enhanced specificity over SYBR Green methods. This approach enables the detection of specific sequences, making it particularly valuable in applications where accuracy is critical, such as clinical diagnostics and genetic testing. The growing emphasis on precision in molecular diagnostics is driving the demand for TaqMan PCR technologies, particularly in oncology and infectious disease research. The ability to multiplex assays further enhances its appeal, allowing researchers to analyze multiple targets in a single reaction. As the demand for high-quality, reliable results continues to rise, TaqMan PCR technology is expected to capture a substantial share of the market.

Reverse Transcription PCR:

Reverse Transcription PCR (RT-PCR) is essential for the quantification of RNA, enabling researchers to study gene expression and viral load assessments. This technique involves the conversion of RNA into complementary DNA (cDNA) before amplification, making it a crucial tool for virology and gene expression studies. The increasing focus on RNA-based research, particularly in the context of infectious diseases and cancer, is significantly boosting the demand for RT-PCR technologies. Furthermore, the integration of RT-PCR with high-throughput screening capabilities is enhancing its utility in research and clinical applications. As the scientific community continues to explore the complexities of gene regulation, the market for RT-PCR technologies is expected to experience substantial growth.

Others:

Other technologies utilized in Real Time PCR machines include multiplex PCR and digital PCR, each offering unique advantages tailored to specific applications. Multiplex PCR enables the simultaneous amplification of multiple targets within the same reaction, streamlining processes in both research and clinical diagnostics. Digital PCR, on the other hand, provides absolute quantification by partitioning samples into numerous individual reactions, enhancing sensitivity and precision. The versatility of these technologies is propelling their adoption across various sectors, including oncology, infectious disease research, and genetic testing. As researchers seek innovative solutions for complex assays, the segment encompassing these advanced technologies is poised for robust growth.

By Region

The North American region is anticipated to dominate the Real Time PCR machines market, accounting for a substantial share due to the presence of advanced healthcare infrastructure, extensive research activities, and a high prevalence of chronic diseases. The region's focus on innovation, combined with significant investments in biotechnology and pharmaceuticals, has created a conducive environment for the adoption of advanced diagnostic technologies. The market in North America is projected to grow at a CAGR of approximately 8.0% during the forecast period, driven by the increasing demand for precision medicine and personalized treatment approaches.

In Europe, the market for Real Time PCR machines is also expected to witness significant growth, driven by the rising emphasis on molecular diagnostics and the growing prevalence of genetic disorders. The region is home to several leading pharmaceutical and biotechnology companies, contributing to a strong research ecosystem that fosters innovation in PCR technology. The European market is projected to grow at a CAGR of around 8.2%, spurred by advancements in assay development and the increasing adoption of real-time PCR in clinical laboratories. Furthermore, countries in the Asia Pacific region are emerging as important players in the market, with significant investments in healthcare infrastructure and research initiatives further propelling growth.

Opportunities

The Real Time PCR machines market presents numerous opportunities driven by technological advancements and evolving healthcare needs. One of the key opportunities lies in the increasing integration of Artificial Intelligence (AI) and machine learning with PCR technologies. These innovations can enhance data analysis, leading to more accurate and faster results, thus increasing the efficiency of diagnostics. Moreover, the rising demand for point-of-care testing in remote locations, particularly in developing countries, presents a significant growth opportunity for portable Real Time PCR machines. As healthcare systems strive for improved accessibility and timely diagnostics, there is a growing emphasis on developing portable and user-friendly solutions that can be deployed in various settings. This trend is likely to drive innovation and expansion in the market.

Furthermore, the growing focus on genomics and personalized medicine is creating opportunities for Real Time PCR applications in drug discovery and development. As pharmaceutical companies increasingly rely on genomic data for targeted therapies, the demand for advanced PCR technologies to facilitate these studies will continue to rise. Additionally, the expanding role of Real Time PCR in agricultural and environmental applications presents an avenue for market growth, as these technologies can be utilized for pathogen detection and genetic analysis in crops. As industries increasingly recognize the value of molecular diagnostics, the Real Time PCR machines market is positioned to capitalize on these emerging opportunities.

Threats

While the Real Time PCR machines market is poised for growth, it also faces several threats that could impact its trajectory. One significant threat is the increasing competition from alternative diagnostic technologies, such as next-generation sequencing (NGS) and other molecular techniques that may offer advantages in certain applications. The rapid advancement of these technologies could overshadow traditional PCR methods, leading to market share erosion for Real Time PCR machines. Additionally, the need for skilled personnel to operate and interpret results from these sophisticated machines poses a challenge, as there is a continuous demand for training and education to keep pace with technological advancements.

Moreover, regulatory challenges can also impact the market, particularly with the increasing scrutiny over diagnostic accuracy and quality standards. Changes in regulations can lead to delays in product approvals and market entry, creating hurdles for manufacturers. Furthermore, budget constraints in healthcare systems, especially in developing regions, could limit the procurement of advanced diagnostic technologies, affecting overall market growth. As stakeholders navigate these challenges, it will be essential to remain agile and responsive to ensure continued progress in the Real Time PCR machines market.

Competitor Outlook

• Applied Biosystems (Thermo Fisher Scientific)
• Bio-Rad Laboratories
• Roche Diagnostics
• Agilent Technologies
• Qiagen N.V.
• Hudson Robotics
• GE Healthcare
• Illumina, Inc.
• PerkinElmer, Inc.
• Meridian Bioscience, Inc.
• Takara Bio Inc.
• Promega Corporation
• Biotium, Inc.
• Sysmex Corporation
• Corbett Life Science (part of QIAGEN)

The competitive landscape of the Real Time PCR machines market is characterized by a mix of global players and specialized manufacturers. Companies like Thermo Fisher Scientific and Bio-Rad Laboratories are at the forefront, leveraging their extensive research capabilities and innovative product offerings to maintain leadership positions in the market. These firms invest heavily in research and development to enhance the performance of their PCR machines and expand their applications across various fields. Their robust distribution networks and strategic partnerships further bolster their market presence, allowing them to reach a diverse customer base across different regions.

Roche Diagnostics and Qiagen N.V. are also significant players in the market, known for their advanced diagnostic solutions. Roche's commitment to innovation in molecular diagnostics, combined with Qiagen's expertise in sample preparation and assay development, positions them as strong contenders in the Real Time PCR segment. Additionally, companies like Agilent Technologies and Illumina, Inc. are increasingly focusing on integrating advanced technologies, such as AI and automation, into their PCR solutions, thereby enhancing efficiency and data accuracy. As the market evolves, these companies are expected to innovate continually, driving competition and improving overall product offerings.

Moreover, several smaller firms and emerging players are entering the Real Time PCR machines market, catering to niche segments and specific applications. Companies such as Hudson Robotics and Biotium, Inc. focus on providing specialized products tailored to unique laboratory needs, thus contributing to the market's diversity. These firms often emphasize customer service and customized solutions, creating a competitive edge in a rapidly changing environment. As more players enter the market, the competitive dynamics are expected to intensify, requiring established companies to adapt and respond to changing customer preferences and technological advancements.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Qiagen N.V.
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Biotium, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 GE Healthcare
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Illumina, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Hudson Robotics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Takara Bio Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 PerkinElmer, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Sysmex Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Promega Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Meridian Bioscience, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Corbett Life Science (part of QIAGEN)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Applied Biosystems (Thermo Fisher Scientific)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Real Time PCR Machines Market, By Application
    • 6.1.1 Clinical Diagnostics
    • 6.1.2 Research
    • 6.1.3 Forensics
    • 6.1.4 Others
  • 6.2 Real Time PCR Machines Market, By Product Type
    • 6.2.1 Standard Real Time PCR Machines
    • 6.2.2 Digital Real Time PCR Machines
    • 6.2.3 Portable Real Time PCR Machines
    • 6.2.4 High-throughput Real Time PCR Machines
    • 6.2.5 Low-throughput Real Time PCR Machines
  • 6.3 Real Time PCR Machines Market, By Distribution Channel
    • 6.3.1 Online Stores
    • 6.3.2 Specialty Stores
    • 6.3.3 Direct Sales
    • 6.3.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Real Time PCR Machines Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Real Time PCR Machines market is categorized based on

By Product Type

• Standard Real Time PCR Machines
• Digital Real Time PCR Machines
• Portable Real Time PCR Machines
• High-throughput Real Time PCR Machines
• Low-throughput Real Time PCR Machines

By Application

• Clinical Diagnostics
• Research
• Forensics
• Others

By Distribution Channel

• Online Stores
• Specialty Stores
• Direct Sales
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Applied Biosystems (Thermo Fisher Scientific)
• Bio-Rad Laboratories
• Roche Diagnostics
• Agilent Technologies
• Qiagen N.V.
• Hudson Robotics
• GE Healthcare
• Illumina, Inc.
• PerkinElmer, Inc.
• Meridian Bioscience, Inc.
• Takara Bio Inc.
• Promega Corporation
• Biotium, Inc.
• Sysmex Corporation
• Corbett Life Science (part of QIAGEN)